[Federal Register Volume 85, Number 196 (Thursday, October 8, 2020)]
[Notices]
[Pages 63583-63584]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22070]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-642]


Importer of Controlled Substances Application: MMJ Biopharma 
Cultivation, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before November 9, 
2020. Such persons may also file a written request for a hearing on the 
application on or before November 9, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn:

[[Page 63584]]

Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 
22152; and (2) Drug Enforcement Administration, Attn: DEA Federal 
Register Representative/DPW, 8701 Morrissette Drive, Springfield, 
Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on February 13, 2020, MMJ Biopharma Cultivation, Inc., 
71 Margaret Terrance Memorial Way, Akwesasne, New York, 13655, applied 
to be registered as an importer of the following basic class(es) of 
controlled substances:

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Marihuana Extract..................            7350  I
Marihuana..........................            7360  I
Tetrahydrocannabinols..............            7370  I
------------------------------------------------------------------------

    The company plans to import the listed controlled substances as 
mature plants to support the manufacturing of dosage forms for use in 
clinical trials. This notice does not constitute an evaluation or 
determination of the merits of the company's application.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-22070 Filed 10-7-20; 8:45 am]
BILLING CODE 4410-09-P